{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:39:17Z","timestamp":1790912357887,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The National Institute for Medical Research Development","award":["971370"],"award-info":[{"award-number":["971370"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-020-00378-1","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T10:54:07Z","timestamp":1610189647000},"page":"23-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Chromone\u2013lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities"],"prefix":"10.1007","volume":"29","author":[{"given":"Leili","family":"Jalili-Baleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Nadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Forootanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuba T\u00fcyl\u00fc","family":"K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyza","family":"Ayazg\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sharifzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahban","family":"Rahimifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Baeeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Foroumadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-7259","authenticated-orcid":false,"given":"Mehdi","family":"Khoobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"key":"378_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, Laferla FM. Alzheimer\u2019s disease. N Engl J Med. 2010;362:329\u201344.","journal-title":"N Engl J Med."},{"key":"378_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Ekavali AS. A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67:195\u2013203.","journal-title":"Pharmacol Rep."},{"key":"378_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol. 2018;14:450\u201364.","journal-title":"Redox Biol."},{"key":"378_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4103\/1673-5374.265544","volume":"15","author":"FQ Zhang","year":"2020","unstructured":"Zhang FQ, Jiang JL, Zhang JT, Niu H, Fu XQ, Zeng LL. Current status and future prospects of stem cell therapy in Alzheimer\u2019s disease. Neural Regen Res. 2020;15:242\u201350.","journal-title":"Neural Regen Res."},{"key":"378_CR5","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1582-4934.2010.01038.x","volume":"14","author":"P Nilsson","year":"2010","unstructured":"Nilsson P, Iwata N, Muramatsu S, Tjernberg LO, Winblad B, Saido TC. Gene therapy in Alzheimer\u2019s disease-potential for disease modification. J Cell Mol Med. 2010;14:741\u201357.","journal-title":"J Cell Mol Med."},{"key":"378_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","volume":"13","author":"G Mushtaq","year":"2014","unstructured":"Mushtaq G, Greig NH, Khan JA, Kamal MA. Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus. CNS Neurol Disord Drug Targets. 2014;13:1432\u20139.","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"378_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","volume":"71","author":"S Darvesh","year":"2012","unstructured":"Darvesh S, Cash MK, Reid GA, Martin E, Mitnitski A, Geula C. Butyrylcholinesterase is associated with \u03b2-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2012;71:2\u201314.","journal-title":"J Neuropathol Exp Neurol."},{"key":"378_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cbi.2010.01.003","volume":"187","author":"E Podoly","year":"2010","unstructured":"Podoly E, Hanin G, Soreq H. Alanine-to-threonine substitutions and amyloid diseases: butyrylcholinesterase as a case study. Chem Biol Interact. 2010;187:64\u201371.","journal-title":"Chem Biol Interact."},{"key":"378_CR9","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1039\/C6RA26737H","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu Z, Zhang A, Sun H, Han Y, Kong L, Wang X. Two decades of new drug discovery and development for Alzheimer\u2019s disease. RSC Adv. 2017;7:6046\u201358.","journal-title":"RSC Adv."},{"key":"378_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/jm7009364","volume":"51","author":"A Cavalli","year":"2008","unstructured":"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C. Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem. 2008;51:347\u201372.","journal-title":"J Med Chem."},{"key":"378_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1021\/acschemneuro.8b00069","volume":"9","author":"M Jesus Oset-Gasque","year":"2018","unstructured":"Jesus Oset-Gasque M, Marco-Contelles J. Alzheimer\u2019s disease, the \u201cOne-Molecule, One-Target\u201d paradigm, and the multitarget directed ligand approach. ACS Chem Neurosci. 2018;9:401\u20133.","journal-title":"ACS Chem Neurosci."},{"key":"378_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.lfs.2018.06.025","volume":"15","author":"TJ Wenzel","year":"2018","unstructured":"Wenzel TJ, Klegeris A. Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer\u2019s disease. Life Sci. 2018;15:314\u201322.","journal-title":"Life Sci."},{"key":"378_CR13","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1039\/C9MD00337A","volume":"10","author":"L Blaikie","year":"2019","unstructured":"Blaikie L, Kay G, Thoo Lin PK. Current and emerging therapeutic targets of alzheimer\u2019s disease for the design of multi-target directed ligands. Med Chem Commun. 2019;10:2052\u201372.","journal-title":"Med Chem Commun."},{"issue":"3","key":"378_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/1673-5374.245463","volume":"14","author":"MM Ibrahim","year":"2019","unstructured":"Ibrahim MM, Gabr MT. Multitarget therapeutic strategies for Alzheimer\u2019s disease. Neural Regen Res. 2019;14(3):437\u201340.","journal-title":"Neural Regen Res."},{"key":"378_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bioorg.2018.04.030","volume":"79","author":"L Jalili-Baleh","year":"2018","unstructured":"Jalili-Baleh L, Nadri H, Forootanfar H, Samzadeh-Kermani A, T\u00fcyl\u00fc K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 T, Ayazgok B, Rahimifard M, Baeeri M, Doostmohammadi M, Firoozpour L, et al. Novel 3-phenylcoumarin\u2013lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer\u2019s disease. Bioorg Chem. 2018a;79:223\u201334.","journal-title":"Bioorg Chem."},{"key":"378_CR16","doi-asserted-by":"crossref","unstructured":"Jalili-Baleh L, Forootanfar H, T\u00fcyl\u00fc K\u00fc\u00e7\u00fckk\u0131l\u0131n\u00e7 T, Nadri H, Abdolahi Z, Ameri A, Jafari M, Ayazgok B, Baeeri M, Rahimifard M, SNA B, et al. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer\u2019s disease based on coumarin and lipoic acid scaffolds. Eur J Med Chem. 2018b;152:600\u201314.","DOI":"10.1016\/j.ejmech.2018.04.058"},{"key":"378_CR17","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.2174\/0929867325666180111101843","volume":"25","author":"SM de Freitas","year":"2018","unstructured":"de Freitas SM, Dias KST, Gontijo VS, Ortiz CJC, Viegas C Jr. Multi-target directed drugs as a modern approach for drug design towards Alzheimer\u2019s disease: an update. Curr Med Chem. 2018;25:3491\u2013525.","journal-title":"Curr Med Chem."},{"key":"378_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/cbdd.12633","volume":"87","author":"RS Keri","year":"2016","unstructured":"Keri RS, Quintanova C, Chaves S, Silva DF, Cardoso SM, Santos MA. New tacrine hybrids with natural-based cysteine derivatives as multi targeted drugs for potential treatment of Alzheimer\u2019s disease. Chem Boil Drug Des. 2016a;87:101\u201311.","journal-title":"Chem Boil Drug Des."},{"key":"378_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejmech.2018.03.057","volume":"151","author":"S Choudhary","year":"2018","unstructured":"Choudhary S, Kumar Singh P, Verma H, Singh H, Silakari O. Success stories of natural product-based hybrid molecules for multifactorial diseases. Eur J Med Chem. 2018b;151:62\u201397.","journal-title":"Eur J Med Chem."},{"issue":"19","key":"378_CR20","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1021\/acs.jmedchem.6b01720","volume":"60","author":"J Reis","year":"2017","unstructured":"Reis J, Gaspar A, Milhazes N, Borges F. Chromone as a privileged scaffold in drug discovery: recent advances. J Med Chem. 2017;60(19):7941\u201357.","journal-title":"J Med Chem."},{"issue":"1","key":"378_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/14756366.2018.1545766","volume":"34","author":"I Pach\u00f3n-Angona","year":"2019","unstructured":"Pach\u00f3n-Angona I, Refouvelet B, Andr\u00fds R, Martin H, Luzet V, Iriepa I, Moraleda I, Diez-Iriepa D, Oset-Gasque MJ, Marco-Contelles J, Musilek K, Ismaili L. Donepezil+chromone+melatonin hybrids as promising agents for Alzheimer\u2019s disease therapy. J Enzy Inhib Med Chem. 2019;34(1):479\u201389.","journal-title":"J Enzy Inhib Med Chem."},{"key":"378_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1472-6882-13-120","volume":"13","author":"S Kumar","year":"2013","unstructured":"Kumar S, Mishra A, Pandey AK. Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models. BMC Compl Altern Med. 2013;13:120.","journal-title":"BMC Compl Altern Med."},{"key":"378_CR23","first-page":"301","volume":"26","author":"S Kumar","year":"2013","unstructured":"Kumar S, Pandey AK. Phenolic content, reducing power and membrane protective activities of Solanum xanthocarpum root extracts. Int J Plant Res. 2013;26:301\u20137.","journal-title":"Int J Plant Res."},{"key":"378_CR24","doi-asserted-by":"publisher","first-page":"6343","DOI":"10.1021\/jf060986h","volume":"54","author":"M Leopoldini","year":"2006","unstructured":"Leopoldini M, Russo N, Chiodo S, Toscano M. Iron chelation by the powerful antioxidant flavonoid quercetin. J Agricul Food Chem. 2006;54:6343\u201351.","journal-title":"J Agricul Food Chem."},{"key":"378_CR25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ejmech.2018.07.056","volume":"158","author":"J Reis","year":"2018","unstructured":"Reis J, Cagide F, Valencia ME, Teixeira J, Bagetta D, P\u00e9rez C, Uriarte E, Oliveira PJ, Ortuso F, Alcaro S, Rodr\u00edguez-Franco MI, Borges F. Multi-target-directed ligands for Alzheimer\u2019s disease: discovery of chromone-based monoamine oxidase\/cholinesterase inhibitors. Eur J Med Chem. 2018;158:781\u2013800.","journal-title":"Eur J Med Chem."},{"key":"378_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8587260","volume":"2017","author":"I Cruz","year":"2017","unstructured":"Cruz I, Puthongking P, Cravo S, et al. Xanthone and flavone derivatives as dual agents with acetylcholinesterase inhibition and antioxidant activity as potential anti-alzheimer agents. J Chem. 2017;2017:e8587260.","journal-title":"J Chem."},{"key":"378_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12263-008-0091-4","volume":"3","author":"D Vauzour","year":"2008","unstructured":"Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JPE. The neuroprotective potential of flavonoids: a multiplicity of effects. Gene Nutr. 2008;3:115\u201326.","journal-title":"Gene Nutr."},{"key":"378_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuint.2015.09.006","volume":"90","author":"SF Nabavi","year":"2015","unstructured":"Nabavi SF, Braidy N, Habtemariam S, Orhan IE, Daglia M, Manayi A, Gortzi O, Nabavi SM. Neuroprotective effects of chrysin: from chemistry to medicine. Neurochem Int. 2015;90:224\u201331.","journal-title":"Neurochem Int."},{"key":"378_CR29","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.bmcl.2011.01.116","volume":"21","author":"R Gautam","year":"2011","unstructured":"Gautam R, Jachak SM, Kumar V, Mohan CG. Synthesis, biological evaluation and molecular docking studies of stellatin derivatives a cyclooxygenase (COX-1, COX-2) inhibitors and anti-inflammatory agents. Bioorg Med Chem Lett. 2011;21:1612\u20136.","journal-title":"Bioorg Med Chem Lett."},{"key":"378_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejmech.2017.10.006","volume":"141","author":"G Nesi","year":"2017","unstructured":"Nesi G, Chen Q, Sestito S, Digiacomo M, Yang X, Wang S, Pi R, Rapposelli S. Nature-based molecules combined with rivastigmine: a symbiotic approach for the synthesis of new agents against Alzheimer\u2019s disease. Eur J Med Chem. 2017;141:232\u20139.","journal-title":"Eur J Med Chem."},{"key":"378_CR31","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1080\/09168451.2015.1027655","volume":"79","author":"A Iida","year":"2015","unstructured":"Iida A, Usui T, Zar Kalai F, Han J, Isoda H, Nagumo Y. Protective effects of Nitraria retusa extract and its constituent isorhamnetin against amyloid binduced cytotoxicity and amyloid b aggregation. Biosci Biotechnol Biochem. 2015;79:1548\u201351.","journal-title":"Biosci Biotechnol Biochem."},{"key":"378_CR32","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1021\/jm201460y","volume":"55","author":"MI Fernandez-Bachiller","year":"2012","unstructured":"Fernandez-Bachiller MI, Perez C, Monjas L, Rademann J, Rodriguez-Franco MI. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer\u2019s disease, with cholinergic, antioxidant, and \u03b2-amyloid-reducing properties. J Med Chem. 2012;55:1303\u201317.","journal-title":"J Med Chem."},{"key":"378_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/taap.2002.9437","volume":"182","author":"H Moini","year":"2002","unstructured":"Moini H, Packer L, Saris NEL. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol. 2002;182:84\u201390.","journal-title":"Toxicol Appl Pharmacol."},{"key":"378_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.pharmthera.2006.07.001","volume":"113","author":"L Holmquist","year":"2007","unstructured":"Holmquist L, Stuchbury G, Berbaum K, Muscat S, Young S, Hager K, Engel J, M\u00fcnch G. Lipoic acid as a novel treatment for Alzheimer\u2019s disease and related dementias. Pharmacol Ther. 2007;113:154\u201364.","journal-title":"Pharmacol Ther."},{"key":"378_CR35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.addr.2008.04.015","volume":"60","author":"A Maczurek","year":"2008","unstructured":"Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, Carlson DA, M\u00fcnch G. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer\u2019s disease. Ad Drug Deliv Rev. 2008;60:1463\u201370.","journal-title":"Ad Drug Deliv Rev."},{"issue":"2","key":"378_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2005.12.014","volume":"28","author":"JF Quinn","year":"2007","unstructured":"Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW Jr. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging. 2007;28(2):213\u201325.","journal-title":"Neurobiol Aging."},{"key":"378_CR37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/jm049112h","volume":"48","author":"M Rosini","year":"2005","unstructured":"Rosini M, Andrisano V, Bartolini M, Bolognesi ML, Hrelia P, Minarini A, Tarozzi A, Melchiorre C. Rational approach to discover multipotent anti-Alzheimer drugs. J Med Chem. 2005;48:360\u20133.","journal-title":"J Med Chem."},{"key":"378_CR38","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bmc.2015.01.005","volume":"23","author":"Z Sanga","year":"2015","unstructured":"Sanga Z, Lia Y, Qiang X, Xiao G, Liu Q, Tan Z, Deng Y. Multifunctional scutellarin\u2013rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem. 2015;23:668\u201380.","journal-title":"Bioorg Med Chem."},{"key":"378_CR39","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.2174\/0929867325666180209132125","volume":"25","author":"C Airoldi","year":"2018","unstructured":"Airoldi C, La Ferla B, D\u2019Orazio G, Ciaramelli C. Palmioli A flavonoids in the treatment of Alzheimer\u2019s and other neurodegenerative diseases. Curr Med Chem. 2018;25:3228\u201346.","journal-title":"Curr Med Chem."},{"key":"378_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ejmech.2018.05.004","volume":"152","author":"L Jalili-Baleh","year":"2018","unstructured":"Jalili-Baleh L, Babaei E, Abdpour S, Bukhari SNA, Foroumadi A, Ramazani A, Sharifzadeh M, Abdollahi M, Khoobi M. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer\u2019s disease. Eur J Med Chem. 2018;152:570\u201389.","journal-title":"Eur J Med Chem."},{"key":"378_CR41","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1016\/j.ejmech.2008.12.027","volume":"44","author":"G Melagraki","year":"2009","unstructured":"Melagraki G, Afantitis A, Igglessi-Markopoulou O, Detsi A, Koufaki M, Kontogiorgis C, Hadjipavlou-Litina DJ. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts. Eur J Med Chem. 2009;44:3020\u20136.","journal-title":"Eur J Med Chem."},{"key":"378_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0167-4943(01)00104-2","volume":"32","author":"K Hager","year":"2001","unstructured":"Hager K, Marahrens A, Kenklies M, Riederer P, Munch G. R-Lipoic acid as a new treatment option for Alzheimer type dementia. Arch Gerontol Geriatr. 2001;32:275\u201382.","journal-title":"Arch Gerontol Geriatr."},{"key":"378_CR43","doi-asserted-by":"publisher","first-page":"112180","DOI":"10.1016\/j.ejmech.2020.112180","volume":"192","author":"Z Sang","year":"2020","unstructured":"Sang Z, Wang K, Shi J, Liu W, Cheng X, Zhu G, Wang Y, Zhao Y, Qiao Z, Wu A, Tan Z. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease. Eur J Med Chem. 2020;192:112180.","journal-title":"Eur J Med Chem."},{"key":"378_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/138161209787315585","volume":"15","author":"ML Bolognesi","year":"2009","unstructured":"Bolognesi ML, Rosini M, Andrisano V, Bartolini M, Minarini A, Tumiatti V, Melchiorre C. MTDL design strategy in the context of Alzheimer\u2019s disease: from lipocrine to memoquin and beyond. Curr Pharm Des. 2009;15:601\u201313.","journal-title":"Curr Pharm Des."},{"key":"378_CR45","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1002\/asia.201100432","volume":"6","author":"SG Agalave","year":"2011","unstructured":"Agalave SG, Maujan SR, Pore VS. Click chemistry: 1,2,3-Triazoles as pharmacophores. Chem Asian J. 2011;6:2696\u2013718.","journal-title":"Chem Asian J."},{"key":"378_CR46","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ejmech.2019.07.059","volume":"180","author":"M Xu","year":"2019","unstructured":"Xu M, Peng Y, Zhu L, Wang S, Ji J, Rakesh KP. Triazole derivatives as inhibitors of Alzheimer\u2019s disease: current developments and structure-activity relationships. Eur J Med Chem. 2019;180:656\u201372.","journal-title":"Eur J Med Chem."},{"key":"378_CR47","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bioorg.2018.10.065","volume":"83","author":"A Rastegari","year":"2019","unstructured":"Rastegari A, Nadri H, Mahdavi M, Moradi A, Mirfazli SS, Edraki N, Moghadam FH, Larijani B, Akbarzadeh T, Saeedi M. Design, synthesis and anti-Alzheimer\u2019s activity of novel 1,2,3-triazole-chromenone carboxamide derivatives. Bioorg Chem. 2019;83:391\u2013401.","journal-title":"Bioorg Chem."},{"key":"378_CR48","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1016\/j.tetlet.2014.04.051","volume":"55","author":"MM Naik","year":"2014","unstructured":"Naik MM, Tilve SG. Pyrrolidine and iodine catalyzed domino aldol-Michael-dehydrogenative synthesis of flavones. Tetrahedron Lett. 2014;55:3340\u20133.","journal-title":"Tetrahedron Lett."},{"key":"378_CR49","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/j.bmc.2011.04.010","volume":"19","author":"G Sagrera","year":"2011","unstructured":"Sagrera G, Bertucci A, Vazquez A, Seoane G. Synthesis and antifungal activities of natural and synthetic bioflavonoids. Bioorg Med Chem. 2011;19:3060\u201373.","journal-title":"Bioorg Med Chem."},{"key":"378_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/jm00105a039","volume":"34","author":"JC Jaen","year":"1991","unstructured":"Jaen JC, Wise LD, Heffner TG, Pugsley TA, Meltzer LT. Dopamine auto receptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones. J Med Chem. 1991;34:248\u201356.","journal-title":"J Med Chem."},{"key":"378_CR51","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1016\/j.bmc.2013.09.061","volume":"21","author":"W Luo","year":"2013","unstructured":"Luo W, Su YB, Hong C, Tian RG, Su LP, Wang YQ, Li Y, Yue JJ, Wang CJ. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents. Bioorg Med Chem. 2013;21:7275\u201382.","journal-title":"Bioorg Med Chem."},{"key":"378_CR52","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1039\/c2jm15530c","volume":"22","author":"T Wu","year":"2012","unstructured":"Wu T, Zhang Q, Hu J, Zhang G, Liu S. Composite silica nanospheres covalently anchored with gold nanoparticles at the outer periphery of thermoresponsive polymer brushes. J Mater Chem. 2012;22:5155\u201363.","journal-title":"J Mater Chem."},{"key":"378_CR53","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.bmcl.2011.03.010","volume":"21","author":"D Garin","year":"2011","unstructured":"Garin D, Oukhatar F, Mahon AB, Try AC, Dubois-Dauphin M, Laferla FM, Demeunynck M, Sallanon MM, Chierici S. Proflavine derivatives as fluorescent imaging agents of amyloid deposits. Bioorg Med Chem Lett. 2011;21:2203\u20136.","journal-title":"Bioorg Med Chem Lett."},{"key":"378_CR54","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.brainresbull.2003.09.011","volume":"62","author":"D Zsolt","year":"2003","unstructured":"Zsolt D, Juh\u00e1sz A, G\u00e1lfi M, So\u00f3s K, Papp R, Z\u00e1dori D, Penke B. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma. Cells Brain Res Bull. 2003;62:223\u20139.","journal-title":"Cells Brain Res Bull."},{"key":"378_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88\u201395.","journal-title":"Biochem Pharmacol."},{"key":"378_CR56","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/pro.5560020312","volume":"20","author":"H Levine","year":"1993","unstructured":"Levine H. Thioflavine T interaction with synthetic Alzheimer\u2019s disease beta-amyloid peptide: detection of amyloid aggregation in solution. Protein Sci. 1993;20:404\u201310.","journal-title":"Protein Sci."},{"key":"378_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.fct.2016.12.008","volume":"100","author":"M Baeeri","year":"2017","unstructured":"Baeeri M, Momtaz S, Navaei-Nigjeh M, Niaz K, Rahimifard M, GhasemiNiri SF, Sanadgol N, Hodjat M, Sharifzadeh M, Abdollahi M. Molecular evidence on the protective effect of ellagic acid on phosaloneinduced senescence in rat embryonic fibroblast cells. Food Chem Toxicol. 2017;100:8\u201323.","journal-title":"Food Chem Toxicol."},{"key":"378_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","volume":"299","author":"IFF Benzie","year":"1999","unstructured":"Benzie IFF, Strain JJ. Ferric reducing\/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299:15\u201327.","journal-title":"Methods Enzymol."},{"key":"378_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10847-012-0219-4","volume":"77","author":"A Pazik","year":"2013","unstructured":"Pazik A, Skwierawska A. Synthesis and spectroscopic properties of new bis-tetrazoles. J Incl Phenom Macrocycl Chem. 2013;77:83\u201394.","journal-title":"J Incl Phenom Macrocycl Chem."},{"key":"378_CR60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem. 2010;31:455\u201361.","journal-title":"J Comput Chem."},{"key":"378_CR61","volume-title":"Discovery studio modeling, release, 4","author":"Dassault Syst\u00e8mes BIOVIA","year":"2015","unstructured":"Dassault Syst\u00e8mes BIOVIA. Discovery studio modeling, release, 4. San Diego: Dassault Systemes; 2015."}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-020-00378-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-020-00378-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-020-00378-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T07:42:56Z","timestamp":1697528576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-020-00378-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1007\/s40199-020-00378-1","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}